(New York, NY) — Pfizer says its COVID-19 vaccine for babies and preschoolers is 80-percent effective against Omicron. The New York pharmaceutical giant made that announcement this morning with its German partner BioNTech. Pfizer says three child-size doses of its COVID vax were “well-tolerated” and showed a strong immune response in children ages six-month to five-years-old. Its clinical trial involved more than 16-hundred younger children. Pfizer says it’ll submit its data to the FDA later this week.
